Literature DB >> 9917839

Modulation of cell-extracellular matrix interactions.

J L Sechler1, S A Corbett, M B Wenk, J E Schwarzbauer.   

Abstract

Changes in extracellular matrix (ECM) structure and composition, such as occur during morphogenesis, can have important regulatory effects on cell behavior. Two fibronectin (FN)-based systems have been developed to dissect how cells respond to different types of ECM. One system mimics the provisional matrix of the wound and is composed of FN cross-linked into a fibrin clot matrix. Unlike cells on FN alone, cells on an FN-fibrin matrix are smaller with cortical distribution of actin filaments and membrane ruffles. Addition of the ECM protein tenascin to the FN-fibrin matrix induces a different cell morphology. Thus, matrix composition can have profound effects on cell phenotype. Cells also interact with FN while assembling it into a fibrillar matrix. Using recombinant FNs, a domain that is required for normal progression of FN fibril formation has been identified. During assembly of this recombinant matrix, formation of actin stress fibers and focal adhesions is delayed, demonstrating that changes in FN matrix structure can affect intracellular organization and activation of signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9917839     DOI: 10.1111/j.1749-6632.1998.tb10114.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

Review 1.  Order and disorder: the role of extracellular matrix in epithelial cancer.

Authors:  Derek Radisky; John Muschler; Mina J Bissell
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

2.  Tissue engineering of endothelial cells and the immune response.

Authors:  H Methe; E R Edelman
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

Review 3.  Nanoscale surface modifications of medically relevant metals: state-of-the art and perspectives.

Authors:  Fabio Variola; John B Brunski; Giovanna Orsini; Paulo Tambasco de Oliveira; Rima Wazen; Antonio Nanci
Journal:  Nanoscale       Date:  2010-10-26       Impact factor: 7.790

4.  c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow.

Authors:  Bochuan Li; Jinlong He; Huizhen Lv; Yajin Liu; Xue Lv; Chenghu Zhang; Yi Zhu; Ding Ai
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

5.  Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces.

Authors:  Douglas A Simonetto; Hui-yin Yang; Meng Yin; Thiago M de Assuncao; Jung Hee Kwon; Moira Hilscher; Shuchong Pan; Liu Yang; Yan Bi; Arthur Beyder; Sheng Cao; Robert D Simari; Richard Ehman; Patrick S Kamath; Vijay H Shah
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

6.  Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation.

Authors:  Ryan E Feaver; Bradley D Gelfand; Chong Wang; Martin A Schwartz; Brett R Blackman
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

7.  The subendothelial extracellular matrix modulates JNK activation by flow.

Authors:  Cornelia Hahn; A Wayne Orr; John M Sanders; Krishna A Jhaveri; Martin Alexander Schwartz
Journal:  Circ Res       Date:  2009-03-12       Impact factor: 17.367

Review 8.  Totally tubular: the mystery behind function and origin of the brain ventricular system.

Authors:  Laura Anne Lowery; Hazel Sive
Journal:  Bioessays       Date:  2009-04       Impact factor: 4.345

Review 9.  Tissue-engineered kidney disease models.

Authors:  Teresa M Desrochers; Erica Palma; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2013-12-17       Impact factor: 15.470

10.  Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase.

Authors:  Patrick A Kiely; George S Baillie; Robert Barrett; Deirdre A Buckley; David R Adams; Miles D Houslay; Rosemary O'Connor
Journal:  J Biol Chem       Date:  2009-05-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.